61 episodes

Sexually Transmitted Infections is the world's longest running international journal on sexual health. It aims to keep practitioners, trainees and researchers up to date in the prevention, diagnosis and treatment of all STIs and HIV. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

STI podcast BMJ Group

    • Science
    • 1.0 • 1 Rating

Sexually Transmitted Infections is the world's longest running international journal on sexual health. It aims to keep practitioners, trainees and researchers up to date in the prevention, diagnosis and treatment of all STIs and HIV. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

    World Human T Leukaemia Day: patient, clinician and scientist's perspectives

    World Human T Leukaemia Day: patient, clinician and scientist's perspectives

    On the World HTLV Day (10th November), we focus on how the Human T leukaemia virus affects people, and review new developments in HTLV treatment and vaccination medicine. HTLV is a retrovirus similar to HIV which incorporates its DNA indefinitely into the human CD4 T lymphocytes. It is predominantly transmitted through condomless sex, but also from mother-to-child and through contact with HTLV positive blood. Unlike HIV, HTLV causes severe disease only in about 5% of PLHTLV, so it is easy for HTLV transmission to go unnoticed. The two dominant HTLV associated diseases are Adult T cell leukaemia (ATL) and HTLV-1 associated myelopathy (HAM/TSP).
    Participants:
    STI's Podcast Editor, Dr Fabiola Martin, interview Ms Kristy Blakeborough, Lived experience and UK patient rep; Prof Yoshihisa Yamano, Neurologist St Marianna University Japan; A/P Keith Chappell, University of Queensland.
    Read the blog post: https://blogs.bmj.com/sti/2021/11/10/world_htlv_day/
    Other relevant links:
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2818%2930974-7/fulltext https://gvn.org/who/
    https://pubmed.ncbi.nlm.nih.gov/27965813/
    https://pubmed.ncbi.nlm.nih.gov/33250897/
    https://www.htlvaware.com

    • 18 min
    Impact of HIV infection on COVID-19 clinical outcome

    Impact of HIV infection on COVID-19 clinical outcome

    In this podcast we discuss the reported impact of HIV infection on people who are hospitalised with COVID-19, by reviewing three publications:
    1. Outcomes of COVID-19 Related Hospitalization Among People With HIV in the ISARIC WHO Clinical Characterization Protocol: A Prospective Observational Study. Clinical Infectious Diseases, 23 October 2020 (https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-HIV-2021).
    2.Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis.Nature, Scientific Reports, 18 March 2021 (https://www.nature.com/articles/s41598-021-85359-3).
    3. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS has just been released. WHO Global Clinical Platform, 15 July 2021 (https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1605/5937133).
    STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; and Associated Research Professor Dr Paddy Ssentongo, from the Penn State University, Pennsylvania, USA.
    Read the blog post: https://blogs.bmj.com/sti/2021/09/16/c19-plwh-revisited/

    • 27 min
    2021 World Hepatitis Day

    2021 World Hepatitis Day

    On World Hepatitis Day 2021, we discover how Australian patients, patient advocates and health care providers are working together to reach the WHO elimination targets for chronic Hepatitis C virus infection.
    Professor Gail Matthews, Infectious Diseases Physician and Program Head of Therapeutic Research and Vaccine Program at The Kirby Institute, Ms Carrie Fowlie, CEO of Hepatitis Australia, and Ms Lisa Carter, Patient advocate and peer educator at Hepatitis SA, join Dr Fabiola Martin to discuss the many different approaches needed to eliminate hepatitis C.
    Related blog post: https://blogs.bmj.com/sti/2021/07/27/world-hepatitis-day-2021/

    • 24 min
    STI and HIV 2021 World Congress: taking virtual and accessibility to another level

    STI and HIV 2021 World Congress: taking virtual and accessibility to another level

    July 2021 marks 40 years from the first reports of a 'strange disease' soon to be known as HIV/Aids. In this "very special edition" themed Sexual Diversity and the City, the STI & HIV 2021 World Congress is inviting people from all walks of life, with some being able to participate for free.
    Listen to all the details in this conversation of STI's Social Media Editor Harrison Austin with Henry de Vries, Professor of skin infections at the University of Amsterdam and President of the Congress, and Mark Vermeulen, Executive Director of Aidsfonds – Soa Aids Nederland.
    Sexually Transmitted Infections (https://sti.bmj.com/) is the official journal of the STI & HIV 2021 World Congress, held as a virtual event on 14-17 July. The mission is to address diversity, health, and sexuality in the urban context. This bi-annual meeting is organised by the International Society for STD Research (ISSTDR) in collaboration with the International Union against STI World (IUSTI World) and is dedicated to STI in its broadest sense.
    https://www.stihiv2021.org/

    • 16 min
    HPV vaccine uptake: achievements and challenges

    HPV vaccine uptake: achievements and challenges

    Today we focus on the challenges and success stories of HPV vaccine uptake, specifically in Italy and Australia. The HPV vaccine rollout has translated into a significant reduction in the prevalence of cervical and a**l cancers. Since its discovery, many different strategies have been used to increase and maintain its uptake in school children, both girls and boys.
    STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; Prof Carlo Giaquinto, Director of the Paediatric Infectious Diseases Unit at the Department of Woman's and Child's Health of the University of Padova Prof; and Ian Frazer, Clinical immunologist and scientist, The University of Queensland Diamantina Institute, Brisbane, Australia.
    Read the related blog post: https://blogs.bmj.com/sti/2021/06/04/hpv-vaccine-uptake-achievements-and-challenges/
    Related content from STI:
    https://sti.bmj.com/content/early/2020/09/02/sextrans-2020-054428
    https://sti.bmj.com/content/95/5/386
    https://sti.bmj.com/content/95/8/608
    https://sti.bmj.com/content/early/2020/12/23/sextrans-2020-054726

    • 23 min
    COVID-19 Vaccine and People who live with HIV

    COVID-19 Vaccine and People who live with HIV

    Thousands of people are currently being vaccinated against COVID-19 worldwide. In this podcast, we discuss if the authorised vaccines are useful to people who live with HIV.
    STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Editor in Chief of the STI Journal; Dr Laura Waters, Sexual Health and HIV specialist at The Mortimer Market Centre, London, and chair of BHIVA; and Mr Simon Collins, HIV patient advocate and editor of the HIV Treatment Bulletin at the i-Base.
    Read the related blog post: https://blogs.bmj.com/sti/2021/04/23/2021episode3/
    Related article: https://www.bhiva.org/SARS-CoV-2-vaccine-advice-for-adults-living-with-HIV-plain-english-version-update

    • 24 min

Customer Reviews

1.0 out of 5
1 Rating

1 Rating

Top Podcasts In Science

BBC
BBC Radio 4
BBC Radio 4
BBC Radio 4
Hidden Brain
Charles Schwab